https://scholars.lib.ntu.edu.tw/handle/123456789/627099
標題: | Tyrosine kinase inhibitors modulate dendritic cell activity via confining c-Kit signaling and tryptophan metabolism | 作者: | CHING-LIANG CHU Lee, Yi-Pang Pang, Cheng-Yoong Lin, Huei-Ru Chen, Chang-Shan You, Ren-In |
關鍵字: | 3-dioxygenase; Dendritic cells; Indoleamine-2; Tryptophan metabolism; Tyrosine kinase inhibitors; c-Kit | 公開日期: | 6-三月-2020 | 出版社: | ELSEVIER | 卷: | 82 | 來源出版物: | International immunopharmacology | 摘要: | Dendritic cell (DC)-based vaccine has been established in tumor immunotherapy. Importantly, the efficiency of anti-tumor T-cells in draining lymph nodes is dependent on the status of DCs surrounding in tumors. It has been shown that Indoleamine 2,3-dioxygenase (IDO) plays a key role to induce tolerogenic DCs in tumor microenvironment, and tyrosine kinase inhibitors (TKIs) can suppress the function of IDO in DCs. However, the stimulatory effect of TKI-modified DCs on T cells remains unclear. In this report, we found that one type of TKI-dasatinib can modify DCs to increasing the activation of allogenic T cells. These TKI-modified DCs delayed the onset of B16 melanoma progression in mice. In mechanistic studies, TKIs did not increase the maturation but reduce the expression and phosphorylation levels of IDO and IDO mediated tryptophan metabolism in DCs. In addition, the suppressive effect of TKIs on tryptophan metabolism may be caused by blocking c-Kit pathway in DCs. Furthermore, the increased phosphorylation of general control nonderepressible (GCN2) and decreased expression of aryl hydrocarbon receptor (AhR)/aryl hydrocarbon receptor nuclear translocator (ARNT) were observed in the T cells activated by TKI-modified DCs, suggesting the enhancement of effector function of T cells. These results indicate that TKI could be used to modulate DC immunogenic activity and may potentially be applied in DC-based cancer immunotherapy. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/627099 | ISSN: | 1567-5769 | DOI: | 10.1016/j.intimp.2020.106357 |
顯示於: | 免疫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。